Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report – medRxiv Commentary: PulmCrit Wee – Therapeutic anticoagulation for COVID ICU patients: Is the heparin vial half empty, or half full? Related (results on moderately ill patients): [Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and […]
The post [Preprint] RCT: Full-dose/therapeutic anticoagulation provides no benefit in critically ill patients with Covid-19 appeared first on Links Medicus.
WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19 – World Health Organization Commentary on Twitter (thread – click for more) WHO has greenlighted the J&J vaccine, so it can be rolled out through COVAX & UN agencies! ? COVAX has an agreement for half a billion doses of […]
The post WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19 appeared first on Links Medicus.
Association of Early vs Late Tracheostomy Placement With Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery Author interview: Early vs Late Tracheotomy for Pneumonia and Ventilator Days #Tracheostomy placement no more than 7 days after ventilator support may lower the rates of ventilator-associated pneumonia and ventilator […]
The post M-A: Early tracheostomy may lower the rates of ventilator-associated pneumonia and ventilator duration in critically ill patients appeared first on Links Medicus.
Long Covid isn’t as unique as we thought – Vox
The post Perspective | Long Covid isn’t as unique as we thought appeared first on Links Medicus.
CDC Interim Recommendations for Fully Vaccinated People: An Important First Step – JAMA Original Guidance and Commentaries: New CDC Guideline for fully vaccinated individuals says people can get together indoors without masks. Precautions should continue in public.
The post CDC Interim Recommendations for Fully Vaccinated People: An Important First Step appeared first on Links Medicus.
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots – The BMJ See also: More European nations pause AstraZeneca vaccine use as blood clot reports investigated – CNN AND Denmark, Norway and Iceland suspend AstraZeneca COVID shots after blood clot reports – Reuters Commentary on Twitter Denmark has temporarily suspended […]
The post Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots appeared first on Links Medicus.
NCCN Best Practices Guidance: Management of COVID-19 Infection in Patients with Cancer – National Comprehensive Cancer Network News release: NCCN Provides New COVID-19 Treatment Advice; Updates Vaccine Guidance for Cancer Patients – National Comprehensive Cancer Network
The post NCCN Best Practices Guidance: Management of COVID-19 Infection in Patients with Cancer appeared first on Links Medicus.
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis – The BMJ News release: Update to living systematic review on covid-19 in pregnancy – The BMJ
The post Update to living systematic review on covid-19 in pregnancy appeared first on Links Medicus.
Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline – European Respiratory Journal
The post ERS Guideline: Management of hospitalized adults with COVID-19 appeared first on Links Medicus.
Press release: Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Commentaries: Novavax Reports Its COVID-19 Vaccine is 96% Efficacious, Based on Phase 3 Trial Results – TIME AND Novavax Says Vaccine Is 96% Effective At Preventing Original Covid-19 Virus – Forbes Commentary on […]
The post [Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant appeared first on Links Medicus.